We propose a stratified novel clinical parameter, Extra-Transitional zone PSA Density (ETzD), that reflects the oncological hazard of prostate by hypothetical nucleation of enlarged adenoma, which implies exclusion of the contribution of adenoma enlargement. The gene discussed is KLK3; the disease is adenoma.